Neoantigen DNA vaccine shows promise against aggressive breast cancer …
13 hours ago · A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at ...
Researchers announce updated findings in preventive breast cancer ...
6 days ago · If breast cancer develops, the vaccine is designed to prompt the immune system to attack the tumor and keep it from growing. The study is based on Dr. Tuohy's research that showed that activating ...
New study finds triple-negative breast cancer tumors with ...
Apr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not …
Breast cancer - Latest research and news | Nature
Nov 6, 2024 · Breast cancer articles from across Nature Portfolio. Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk...
FDA expands approval of breast cancer drug Kisqali to ... - NBC News
Sep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's...
Estrogen a more powerful breast cancer culprit than we realized
May 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer News - ScienceDaily
Oct 22, 2024 · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
WHO launches new roadmap on breast cancer
Feb 3, 2023 · The World Health Organization (WHO) released a new Global Breast Cancer Initiative Framework today providing a roadmap to attain the targets to save 2.5 million lives from breast cancer by 2040.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
Jun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Targeted therapy shows benefit for people with advanced breast cancer ...
Dec 8, 2022 · CNN — An experimental treatment shows promise for people with the most common form of advanced-stage breast cancer, according to results from a Phase 3 clinical trial. The details of the trial...